FOXO TECHNOLOGIES INC. Preferred Stock Dividends and Other Adjustments
FOXO TECHNOLOGIES INC. (FOXO) reported Preferred Stock Dividends and Other Adjustments of -$259.05 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. preferred stock dividends and other adjustments for the quarter ending 2026-06-30 was -$259.05K, a 253.72% decline year-over-year.
- FOXO TECHNOLOGIES INC. preferred stock dividends and other adjustments for the quarter ending 2026-03-31 was $284.77K, a 9.57% decline year-over-year.
- FOXO TECHNOLOGIES INC. preferred stock dividends and other adjustments for the quarter ending 2025-12-31 was $306.55K.
- FOXO TECHNOLOGIES INC. preferred stock dividends and other adjustments for the quarter ending 2025-09-30 was $147.83K.
- FOXO TECHNOLOGIES INC. preferred stock dividends and other adjustments for fiscal 2025 was $937.81K, a 1053.15% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. preferred stock dividends and other adjustments for fiscal 2024 was $81.33K.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$259.05K 10-Q · filed 2026-08-14 | $25.72K 10-Q · filed 2026-08-14 | $332.27K derived: sum of 3 quarters · filed 2026-08-14 | $480.10K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $284.77K 10-Q · filed 2026-05-15 | $591.32K derived: sum of 2 quarters · filed 2026-05-15 | $739.15K derived: sum of 3 quarters · filed 2026-05-15 | $907.67K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $306.55K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $454.38K derived: sum of 2 quarters · filed 2026-04-15 | $622.90K derived: sum of 3 quarters · filed 2026-08-14 | $937.81K 10-K · filed 2026-04-15 |
| 2025-09-30 | $147.83K 10-Q · filed 2025-11-10 | $316.35K derived: sum of 2 quarters · filed 2026-08-14 | $631.26K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $168.52K 10-Q · filed 2026-08-14 | $483.43K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $314.91K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $81.33K 10-K · filed 2026-04-15 | |||
| 2023-06-30 | $2.47M 10-Q · filed 2023-08-10 | $2.47M 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |